DEMİR DORA, D. Et Al. 2025. Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of Clinical Medicine , vol.14, no.11 .

DEMİR DORA, D., Tuna, S., Kurtoglu, E. D., Gursoy, S., BALCI, N., Tezman, S., ... Erenmemisoglu, A.(2025). Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of Clinical Medicine , vol.14, no.11.

DEMİR DORA, DEVRİM Et Al. "Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial," Journal of Clinical Medicine , vol.14, no.11, 2025

DEMİR DORA, DEVRİM D. Et Al. "Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial." Journal of Clinical Medicine , vol.14, no.11, 2025

DEMİR DORA, D. Et Al. (2025) . "Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial." Journal of Clinical Medicine , vol.14, no.11.

@article{article, author={DEVRİM DEMİR DORA Et Al. }, title={Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial}, journal={Journal of Clinical Medicine}, year=2025}